Oral Poliovirus Vaccine (opv) - Infectious Diseases

Relevant Publications

Persistent Transmission of Circulating Vaccine-Derived Poliovirus - Somalia, January 2017-March 2024.

Issue Release: 2024

Vaccine-associated paralytic poliomyelitis in oral polio vaccine recipients: disproportionality analysis using VAERS and systematic review.

Issue Release: 2024

Increasing Population Immunity Prior to Globally-Coordinated Cessation of Bivalent Oral Poliovirus Vaccine (bOPV).

Issue Release: 2024

Safety and Immunogenicity of Trivalent Oral Polio Vaccine in Vaccinated Children and Vaccine-Naïve Infants: A Phase 4 Study.

Issue Release: 2024

\"Build back the confidence\": qualitative exploration of community experiences with polio vaccination in the Covid-19 context in Cameroon and Ethiopia.

Issue Release: 2024

Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study.

Issue Release: 2024

Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.

Issue Release: 2024

Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance.

Issue Release: 2024

The Polio Vaccination Status of Non-polio Acute Flaccid Paralysis Cases in the Far North Region of Cameroon: A Five-Year Retrospective Study From 2015 to 2019.

Issue Release: 2024

Progress in Access and Oral Polio Vaccine Coverage Among Children Aged <5 Years in Polio Campaigns After the Political Change in Afghanistan.

Issue Release: 2024

Mucosal immunity to poliovirus in children 0-15 years of age: A community-based study in Karachi, Pakistan in 2019.

Issue Release: 2024

Progresses Toward Polio Eradication in Asian Countries: Its History and Japan\'s Contributions.

Issue Release: 2024

Antisera-Neutralizing Capacity of a Highly Evolved Type 2 Vaccine-Derived Poliovirus from an Immunodeficient Patient.

Issue Release: 2024

Vitamin D Supplementation and Prior Oral Poliovirus Vaccination Decrease Odds of COVID-19 Outcomes among Adults Recently Inoculated with Inactivated Poliovirus Vaccine.

Issue Release: 2024

Safety of incidental exposure to the novel oral poliovirus vaccine type 2 in pregnancy: A longitudinal observational study in Mozambique, 2022-2023.

Issue Release: 2024

Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization.

Issue Release: 2024

Intestinal mucosal immunity is unimportant for polio eradication: the failure of oral polio vaccination.

Issue Release: 2024

Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?

Issue Release: 2024

Detection of Polioviruses Type 2 among Migrant Children Arriving to the Russian Federation from a Country with a Registered Poliomyelitis Outbreak.

Issue Release: 2024

Re-emergence of vaccine-derived polio in the demographic Republic of Congo: Causes and consequences.

Issue Release: 2024

How Are Muscle Aches Diagnosed?

What is the Role of the FDA in Infectious Diseases?

Are There Vaccines Available for Diseases Transmitted by Aedes Aegypti?

What are Respiratory Symptoms?

What are the Strengths and Limitations?

How is Chikungunya Diagnosed?

Why are Genomic Studies Important in Infectious Diseases?

How to Interpret Stool Sample Results?

How can public health responses be improved?

What are the Symptoms of Cervical Cancer?

Oral Poliovirus Vaccine (opv) - Infectious Diseases

Relevant Publications

Partnered Content Networks

Relevant Topics